Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATRS | Common Stock | Award | $112K | +25.5K | +4.69% | $4.42 | 568K | Jun 10, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATRS | Stock Option (right to buy) | Award | $0 | +48.5K | $0.00 | 48.5K | Jun 10, 2021 | Common Stock | 48.5K | $4.42 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest one year from the grant date. The reporting person has elected to defer the receipt of shares until separation of service as a Director. |
F2 | Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan. |
F3 | The options vest and become exercisable one year from the grant date. |